1,377.22
-2.69 (-0.19%)
| Previous Close | 1,379.91 |
| Open | 1,387.07 |
| Volume | 141,472 |
| Avg. Volume (3M) | 134,835 |
| Market Cap | 28,134,461,440 |
| Price / Earnings (TTM) | 32.78 |
| Price / Earnings (Forward) | 28.49 |
| Price / Sales | 6.61 |
| Price / Book | 1.33 |
| 52 Weeks Range | |
| Earnings Date | 30 Apr 2026 |
| Profit Margin | 22.17% |
| Operating Margin (TTM) | 25.19% |
| Diluted EPS (TTM) | 40.10 |
| Quarterly Revenue Growth (YOY) | -4.60% |
| Quarterly Earnings Growth (YOY) | -7.80% |
| Current Ratio (MRQ) | 1.01 |
| Operating Cash Flow (TTM) | 972.81 M |
| Levered Free Cash Flow (TTM) | 743.66 M |
| Return on Assets (TTM) | 21.22% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Diagnostics & Research (US) | Mixed | Bullish |
| Diagnostics & Research (Global) | Mixed | Bullish | |
| Stock | Mettler-Toledo International, I | Bearish | Bullish |
AIStockmoo Score
| Analyst Consensus | 1.0 |
| Insider Activity | NA |
| Price Volatility | 2.0 |
| Technical Moving Averages | -2.5 |
| Technical Oscillators | -0.5 |
| Average | 0.00 |
|
Mettler-Toledo supplies weighing and precision instruments to customers in the life sciences (around 55% of sales), industrial (around 40%), and food retail (around 5%) industries. Its products include laboratory and retail scales, pipettes, pH meters, thermal analysis equipment, titrators, metal detectors, and X-ray analyzers. Mettler leads the market for weighing instrumentation and controls more than 50% of the market for lab balances. The business is geographically diversified, with the Americas accounting for about 37% of sales, Europe about 27%, China about 16% and the rest of the world about 20%. |
|
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Investment Style | Mid Core |
| % Held by Insiders | 0.42% |
| % Held by Institutions | 101.90% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Fundsmith Llp | 31 Dec 2025 | 580,507 |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 1,550.00 (Barclays, 12.55%) | Buy |
| Median | 1,475.00 (7.10%) | |
| Low | 1,450.00 (Wells Fargo, 5.29%) | Hold |
| Average | 1,491.67 (8.31%) | |
| Total | 1 Buy, 2 Hold | |
| Avg. Price @ Call | 1,408.42 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Morgan Stanley | 10 Feb 2026 | 1,475.00 (7.10%) | Hold | 1,400.33 |
| Barclays | 15 Dec 2025 | 1,550.00 (12.55%) | Buy | 1,412.47 |
| Wells Fargo | 15 Dec 2025 | 1,450.00 (5.28%) | Hold | 1,412.47 |
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 05 Feb 2026 | Announcement | Mettler-Toledo International Inc. Reports Fourth Quarter 2025 Results |
| 20 Jan 2026 | Announcement | METTLER TOLEDO Announces Michael J. Tokich to Join Board of Directors |
| 09 Jan 2026 | Announcement | Mettler-Toledo International Inc. to Host Fourth Quarter 2025 Earnings Conference Call |
| 05 Jan 2026 | Announcement | Mettler-Toledo International Inc. to Present at the 44th Annual J.P. Morgan Healthcare Conference |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |